Latest / IMA (Formerly FLCCC Alliance)
#241 (Mar. 14, 2026) 'Drug Cycling in Cancer Care: What It Is and Why It’s Critical': IMA (formerly FLCCC) Weekly Update
What happens when a cancer treatment stops working the way it once did? As tumors adapt and resistance develops, treatment strategy can become a critical part of improving outcomes.
Sign up for weekly webinars: Weekly Webinars - Independent Medical Alliance
In this episode, Dr. Ryan Cole, IMA Head of Medical & Scientific Affairs, speaks with Dr. Paul Marik, IMA Chief Scientific Officer, about the role of drug cycling in cancer care and why it may be essential for patients facing complex treatment decisions.
They cover:
• What drug cycling is and how it is used in cancer care
• Why changing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.